Nuclear expression of GLI1 was observed in 33/51 (65%) carcinoma samples, including 3/10 (30%), 23/31 (74%) and 7/10 (70%) G1, G2 and G3 tumors, respectively. The gene discussed is GLI1; the disease is carcinoma.